Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stem Cell Research

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 89 articles:
HTML format



Single Articles


    August 2021
  1. AGAWA K, Yamashita K, Nakagawa A, Yamada K, et al
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4117-4126.
    PubMed     Abstract available


    July 2021
  2. HYUN CL, Park SJ, Kim HS, Song HJ, et al
    The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Anticancer Res. 2021;41:3689-3698.
    PubMed     Abstract available


  3. LIM JH, Go G, Lee SH
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:3459-3470.
    PubMed     Abstract available


  4. KIM CY, Kim YC, Oh JH, Kim MH, et al
    HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression.
    Anticancer Res. 2021;41:3409-3417.
    PubMed     Abstract available


  5. RUZANOVA VS, Proskurina AS, Ritter GS, Efremov YR, et al
    Experimental Comparison of the In Vivo Efficacy of Two Novel Anticancer Therapies.
    Anticancer Res. 2021;41:3371-3387.
    PubMed     Abstract available


  6. TROSCHEL FM, Linsenmaier M, Borrmann K, Eich HT, et al
    Heparanase Expression Is Associated With Cancer Stem Cell Features and Radioresistance in Hodgkin's Lymphoma Cells.
    Anticancer Res. 2021;41:3299-3308.
    PubMed     Abstract available


    June 2021
  7. SHIN J, Baik SK, Yoon Y, Hwang S, et al
    DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth.
    Anticancer Res. 2021;41:2859-2866.
    PubMed     Abstract available


    March 2021
  8. MO S, Ku HJ, Choi SH, Jeong HJ, et al
    470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
    Anticancer Res. 2021;41:1407-1420.
    PubMed     Abstract available


  9. PARK SY, Seo YR, Ko MJ, Lee JH, et al
    Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression.
    Anticancer Res. 2021;41:1315-1325.
    PubMed     Abstract available


  10. TURNOVCOVA K, Marekova D, Sursal T, Krupova M, et al
    Understanding the Biological Basis of Glioblastoma Patient-derived Spheroids.
    Anticancer Res. 2021;41:1183-1195.
    PubMed     Abstract available


    February 2021
  11. YAMASHITA N, Oyama T, So T, Miyata T, et al
    Association Between CD133 Expression and Prognosis in Human Lung Adenocarcinoma.
    Anticancer Res. 2021;41:905-910.
    PubMed     Abstract available


  12. PAPADAKI MA, Aggouraki D, Vetsika EK, Xenidis N, et al
    Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Anticancer Res. 2021;41:661-670.
    PubMed     Abstract available


    January 2021
  13. THADI A, Morano WF, Khalili M, Babcock BD, et al
    Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells.
    Anticancer Res. 2021;41:27-42.
    PubMed     Abstract available


    December 2020
  14. PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
    Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:6817-6833.
    PubMed     Abstract available


  15. MALAER JD, Mathew PA
    Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells.
    Anticancer Res. 2020;40:6613-6621.
    PubMed     Abstract available


    November 2020
  16. CZYZEWSKI K, DEbski R, Bartoszewicz N, Demidowicz E, et al
    Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Anticancer Res. 2020;40:6531-6537.
    PubMed     Abstract available


  17. NAGASHIMA T, Oshima T, Hiroshima Y, Yokose T, et al
    Clinical Significance of Tumour CD44v and MIST1 Expression in Patients With Non-small-cell Lung Cancer.
    Anticancer Res. 2020;40:6407-6416.
    PubMed     Abstract available


  18. PAN Y, Chiu YH, Chiu SC, Cho DY, et al
    Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells.
    Anticancer Res. 2020;40:6093-6099.
    PubMed     Abstract available


    October 2020
  19. STUDER U, Khanna N, Leuzinger K, Hirsch HH, et al
    Incidence of CMV Replication and the Role of Letermovir Primary/Secondary Prophylaxis in the Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation - A Single Centre Study.
    Anticancer Res. 2020;40:5909-5917.
    PubMed     Abstract available


  20. LI J, Seligson N, Zhang X, Johnson J, et al
    Association of ANRIL Polymorphism With Overall Survival in Adult Patients With Hematologic Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation.
    Anticancer Res. 2020;40:5707-5713.
    PubMed     Abstract available


  21. YENILMEZ EN, Genc D, Farooqi AA, Tunoglu S, et al
    Mesenchymal Stem Cells Combined With IFNgamma Induce Apoptosis of Breast Cancer Cells Partially Through TRAIL.
    Anticancer Res. 2020;40:5641-5647.
    PubMed     Abstract available


  22. GO G, Yun CW, Yoon YM, Lim JH, et al
    Role of PrP(C) in Cancer Stem Cell Characteristics and Drug Resistance in Colon Cancer Cells.
    Anticancer Res. 2020;40:5611-5620.
    PubMed     Abstract available


  23. MIYASHITA M, Tomogane M, Nakamura Y, Shimizu T, et al
    Sphere-derived Prostate Cancer Stem Cells Are Resistant to gammadelta T Cell Cytotoxicity.
    Anticancer Res. 2020;40:5481-5487.
    PubMed     Abstract available


  24. YUNO T, Miyata Y, Matsuo T, Mukae Y, et al
    Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer.
    Anticancer Res. 2020;40:5567-5575.
    PubMed     Abstract available


  25. MARGAN MM, Cimpean AM, Ceausu AR, Raica M, et al
    Differential Expression of E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes.
    Anticancer Res. 2020;40:5557-5566.
    PubMed     Abstract available


  26. JEONG JY, Jeong W, Kim HJ
    Promotion of Chondrosarcoma Cell Survival, Migration and Lymphangiogenesis by Periostin.
    Anticancer Res. 2020;40:5463-5469.
    PubMed     Abstract available


    September 2020
  27. KIM DH, Kang DY, Sp N, Jo ES, et al
    Methylsulfonylmethane Induces Cell Cycle Arrest and Apoptosis, and Suppresses the Stemness Potential of HT-29 Cells.
    Anticancer Res. 2020;40:5191-5200.
    PubMed     Abstract available


    August 2020
  28. KIM BH, Oh HK, Kim DW, Kang SB, et al
    Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.
    Anticancer Res. 2020;40:4481-4489.
    PubMed     Abstract available


    July 2020
  29. CHO JM, Lee HJ, Chung JH, Kim WY, et al
    Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
    Anticancer Res. 2020;40:3801-3809.
    PubMed     Abstract available


    June 2020
  30. AHN SY
    The Role of MSCs in the Tumor Microenvironment and Tumor Progression.
    Anticancer Res. 2020;40:3039-3047.
    PubMed     Abstract available


    April 2020

  31. Cell Biology and Translational Medicine, Volume 6. Stem Cells: Their Heterogeneity, Niche and Regenerative Potential.
    Anticancer Res. 2020;40:2406.
    PubMed    



  32. Essential Current Concepts in Stem Cell Biology.
    Anticancer Res. 2020;40:2405-2406.
    PubMed    



  33. Stem Cell Transcriptional Networks. Methods and Protocols.
    Anticancer Res. 2020;40:2405.
    PubMed    


    March 2020
  34. GOGOLOK J, Seidel E, Stronisch A, Reutzel-Selke A, et al
    Characterization of Pancreatic and Biliary Cancer Stem Cells in Patient-derived Tissue.
    Anticancer Res. 2020;40:1267-1275.
    PubMed     Abstract available


  35. HAYASHI T, Sano K, Ichimura T, Kanai Y, et al
    Characteristics of Leiomyosarcoma: Induction of Hematogenous Metastasis by Isolated Uterine Mesenchymal Tumor Stem-like Cells.
    Anticancer Res. 2020;40:1255-1265.
    PubMed     Abstract available


    February 2020

  36. Epidermal Stem Cell Niche, Volume 3. 1st Edition.
    Anticancer Res. 2020;40:1185.
    PubMed    


  37. KISARETOVA PE, Kirikovich SS, Ritter GS, Efremov YR, et al
    Approbation of the Cancer Treatment Approach Based on the Eradication of TAMRA+ Cancer Stem Cells in a Model of Murine Cyclophosphamide Resistant Lymphosarcoma.
    Anticancer Res. 2020;40:795-805.
    PubMed     Abstract available


  38. IWAHASI S, Rui F, Morine Y, Yamada S, et al
    Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.
    Anticancer Res. 2020;40:743-749.
    PubMed     Abstract available


    January 2020
  39. OKUYAMA H, Nogami W, Sato Y, Yoshida H, et al
    Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
    Anticancer Res. 2020;40:169-176.
    PubMed     Abstract available


  40. LI J, Vangundy Z, Poi M
    PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
    Anticancer Res. 2020;40:133-141.
    PubMed     Abstract available


    December 2019
  41. HAN HR, Park SA, Ahn S, Jeun SS, et al
    Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.
    Anticancer Res. 2019;39:6635-6643.
    PubMed     Abstract available


  42. TANAKA H, Kawaguchi M, Shoda S, Miyoshi T, et al
    Nuclear Accumulation of beta-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
    Anticancer Res. 2019;39:6575-6583.
    PubMed     Abstract available


    November 2019
  43. ROMANENKO MV, Dolgova EV, Osipov ID, Ritter GS, et al
    Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.
    Anticancer Res. 2019;39:6073-6086.
    PubMed     Abstract available


  44. TODA Y, Yoshimura R, Itahara M, Imai Y, et al
    DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line.
    Anticancer Res. 2019;39:5983-5990.
    PubMed     Abstract available


    October 2019
  45. ZAIMOKU R, Miyashita T, Tajima H, Takamura H, et al
    Monitoring of Heat Shock Response and Phenotypic Changes in Hepatocellular Carcinoma After Heat Treatment.
    Anticancer Res. 2019;39:5393-5401.
    PubMed     Abstract available


    September 2019
  46. INTUYOD K, Hahnvajanawong C, Pinlaor P, Pinlaor S, et al
    Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro.
    Anticancer Res. 2019;39:4837-4843.
    PubMed     Abstract available


  47. SANOMACHI T, Suzuki S, Togashi K, Seino S, et al
    Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer.
    Anticancer Res. 2019;39:4817-4828.
    PubMed     Abstract available


  48. GE H, Cheng N, Xu X, Yang Z, et al
    AMMECR1 Inhibits Apoptosis and Promotes Cell-cycle Progression and Proliferation of the A549 Human Lung Cancer Cell Line.
    Anticancer Res. 2019;39:4637-4642.
    PubMed     Abstract available


    August 2019
  49. SINHA AA
    Electron Microscopic Analysis of Stem Cells in Human Prostate Cancer, Including Inverted Capsule Embedding Methods for Archival Sections and Falcon Films for Prostate Cancer Cell Lines.
    Anticancer Res. 2019;39:4171-4177.
    PubMed     Abstract available


    June 2019
  50. GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
    The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Anticancer Res. 2019;39:2689-2697.
    PubMed     Abstract available


    April 2019
  51. ISHIBASHI N, Maebayashi T, Sakaguchi M, Aizawa T, et al
    Myelosuppression After Radiation Therapy in Patients With and Without Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Observational Study.
    Anticancer Res. 2019;39:2163-2167.
    PubMed     Abstract available


  52. MASTER S, Koshy N, Mansour R, Shi R, et al
    Effect of Stem Cell Transplant on Survival in Adult Patients With Acute Lymphoblastic Leukemia: NCDB Analysis.
    Anticancer Res. 2019;39:1899-1906.
    PubMed     Abstract available


  53. OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
    The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
    Anticancer Res. 2019;39:1719-1728.
    PubMed     Abstract available


    March 2019

  54. Hepatic Stem Cells.
    Anticancer Res. 2019;39:1631.
    PubMed    


  55. MURAKI Y, Hasegawa T, Takeda D, Ueha T, et al
    Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1205-1216.
    PubMed     Abstract available


  56. VASYUTIN I, Zerihun L, Ivan C, Atala A, et al
    Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling.
    Anticancer Res. 2019;39:1105-1118.
    PubMed     Abstract available


    February 2019
  57. YAMAMOTO M, Suzuki S, Togashi K, Sanomachi T, et al
    AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1.
    Anticancer Res. 2019;39:609-617.
    PubMed     Abstract available


  58. SAKAMOTO D, Takagi T, Fujita M, Omura S, et al
    Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma.
    Anticancer Res. 2019;39:597-607.
    PubMed     Abstract available


    January 2019
  59. STELLA S, Massimino M, Tirro E, Vitale SR, et al
    B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR-ABL Transcripts: A Case Report.
    Anticancer Res. 2019;39:431-435.
    PubMed     Abstract available


  60. NUMAKURA S, Uozaki H, Kikuchi Y, Watabe S, et al
    Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
    Anticancer Res. 2019;39:387-393.
    PubMed     Abstract available


  61. KIM KH, Cheong HJ, Lee MY, Lee N, et al
    Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
    Anticancer Res. 2019;39:127-133.
    PubMed     Abstract available


  62. KAWAGUCHI-IHARA N, Zhao Y, Nakamura S, Suzuki K, et al
    Chloroquine Inhibits Self-Renewal of Blast Progenitors Synergistically With Phytochemicals or Nonsteroidal Anti-inflammatory Drugs in Hematological Malignant Cell Lines.
    Anticancer Res. 2019;39:87-98.
    PubMed     Abstract available


    December 2018
  63. KIM J, Ahn S, Kim K, Cho MS, et al
    Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:6881-6889.
    PubMed     Abstract available


  64. YAMAMOTO M, Suzuki S, Togashi K, Sanomachi T, et al
    AS602801, an Anticancer Stem Cell Candidate Drug, Reduces Survivin Expression and Sensitizes A2780 Ovarian Cancer Stem Cells to Carboplatin and Paclitaxel.
    Anticancer Res. 2018;38:6699-6706.
    PubMed     Abstract available


    November 2018
  65. HEATH EI, Heilbrun LK, Smith D, Schopperle WM, et al
    Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.
    Anticancer Res. 2018;38:6361-6366.
    PubMed     Abstract available


  66. FU S, Lin J
    Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells.
    Anticancer Res. 2018;38:6271-6279.
    PubMed     Abstract available


    October 2018
  67. SINHA AA, Wilson MJ
    Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133.
    Anticancer Res. 2018;38:5725-5732.
    PubMed     Abstract available


    September 2018
  68. KURAMOTO K, Yamamoto M, Suzuki S, Sanomachi T, et al
    AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes.
    Anticancer Res. 2018;38:5093-5099.
    PubMed     Abstract available


  69. TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
    Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
    Anticancer Res. 2018;38:5531-5537.
    PubMed     Abstract available


  70. YANG WH, Cheng CY, Chen MF, Wang TC, et al
    Cell Subpopulations Overexpressing p75NTR Have Tumor-initiating Properties in the C6 Glioma Cell Line.
    Anticancer Res. 2018;38:5183-5192.
    PubMed     Abstract available


    August 2018
  71. FUNATO M, Ozeki M, Suzuki A, Ishihara M, et al
    Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
    Anticancer Res. 2018;38:4691-4697.
    PubMed     Abstract available


  72. TOGASHI K, Okada M, Yamamoto M, Suzuki S, et al
    A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
    Anticancer Res. 2018;38:4535-4542.
    PubMed     Abstract available


    July 2018
  73. CHANDIMALI N, Huynh DL, Jin WY, Kwon T, et al
    Combination Effects of Hispidin and Gemcitabine via Inhibition of Stemness in Pancreatic Cancer Stem Cells.
    Anticancer Res. 2018;38:3967-3975.
    PubMed     Abstract available


  74. MAIUTHED A, Chantarawong W, Chanvorachote P
    Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
    Anticancer Res. 2018;38:3797-3809.
    PubMed     Abstract available


    June 2018
  75. KOESSINGER D, Albrecht V, Faber F, Jaehnert I, et al
    ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells.
    Anticancer Res. 2018;38:3347-3355.
    PubMed     Abstract available


    May 2018
  76. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
    Effect of Tissue Factor on Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:2635-2642.
    PubMed     Abstract available


  77. NASSEREDDINE S, Alsubait S, Tabbara I
    Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
    Anticancer Res. 2018;38:2597-2605.
    PubMed     Abstract available


  78. KAWAMOTO M, Umebayashi M, Tanaka H, Koya N, et al
    Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
    Anticancer Res. 2018;38:2739-2748.
    PubMed     Abstract available


    April 2018
  79. TERASAKI M, Ogawa Y, Endo T, Maeda H, et al
    Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
    Anticancer Res. 2018;38:2169-2179.
    PubMed     Abstract available


  80. SANTORO R, Zanotto M, Carbone C, Piro G, et al
    MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
    Anticancer Res. 2018;38:1937-1946.
    PubMed     Abstract available


    March 2018
  81. KANEKO S, Sato C, Shiozawa N, Sato A, et al
    Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
    Anticancer Res. 2018;38:1391-1399.
    PubMed     Abstract available


    February 2018
  82. KANG S, Oh SC, Min BW, Lee DH, et al
    Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:787-794.
    PubMed     Abstract available


    January 2018
  83. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Abstract available


  84. LAPINSKA K, Faria G, McGonagle S, Macumber KM, et al
    Cancer Progenitor Cells: The Result of an Epigenetic Event?
    Anticancer Res. 2018;38:1-6.
    PubMed     Abstract available


    November 2017
  85. SANOMACHI T, Suzuki S, Kuramoto K, Takeda H, et al
    Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
    Anticancer Res. 2017;37:6177-6188.
    PubMed     Abstract available


    October 2017
  86. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Abstract available


  87. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Abstract available


    September 2017
  88. JUNGBAUER F, Aderhold C, Birk R, Hoermann K, et al
    Communicate or Die - A Model for HPV+ and HPV- CSCs and Their Interactions with SDF-1alpha.
    Anticancer Res. 2017;37:4827-4836.
    PubMed     Abstract available


  89. GOMES JPA, Assoni AF, Pelatti M, Coatti G, et al
    Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
    Anticancer Res. 2017;37:4747-4758.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: